It's basically what makes us hungry and makes us stop eating when we are full
Its a novel drug that combines the effects of two hormones, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide), which play significant roles in regulating blood sugar, appetite, and fat metabolism
After this initial period, you can switch to maintenance doses every 2 to 3 weeks to help preserve your results and support ongoing metabolism
LBA 16 Weigert, C
In the U.K., once supply issues are sorted out, Wegovy will only be available to severely obese adults who have at least one additional weight-related condition, such as heart disease or high blood pressure, a body mass index (BMI) of more than 35, prescribed only within an NHS-authorized specialist weight-management scheme and for a maximum of two years
doi: 10.1161/ATVBAHA.120.315267 204 NotzQ.HerrmannJ.SchlesingerT.HelmerP.SudoweS.SunQ.et al